Pharmacy Insights

Pharmacy Insights

  • Healthcare
  • Pharmacy

GLP-1 Series Part 4: End of Mounjaro’s bridge program drove improved gross-to-net

Feb 16, 2024
  • Healthcare
  • Pharmacy

GLP-1 Series Part 3: Mounjaro driving largest declines in insulin usage

Feb 16, 2024
  • Healthcare
  • Pharmacy

GLP-1 Series Part 2: Mounjaro persistence beats Ozempic in type II diabetes

Feb 16, 2024
  • Healthcare
  • Pharmacy

GLP-1 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes

Feb 16, 2024
  • Healthcare
  • Pharmacy

Discontinuations damper Relyvrio’s launch

Nov 27, 2023
  • Healthcare
  • Pharmacy

Orladeyo: A Tough Pill to Swallow for Competitors in the HAE Space 

Nov 14, 2023
arrow-downarrow-leftarrow-rightcaret-down-menucaret-downcarrot-rightcheckclosefacebook-squarefilterhamburgerinstagram-squarelinkedin-squaremobile-parent-indicatorpauseplayprintertwitter-square